Connection

Nisreen Okba to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Nisreen Okba has written about Coronavirus Infections.
Nisreen Okba
Connection Strength
0.220
Coronavirus Infections
  1. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Emerg Microbes Infect. 2020 Dec; 9(1):1080-1091.
    View in: PubMed
    Score: 0.029
  2. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg Infect Dis. 2020 Jul; 26(7):1478-1488.
    View in: PubMed
    Score: 0.028
  3. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies. Emerg Infect Dis. 2020 May; 26(5):1024-1027.
    View in: PubMed
    Score: 0.028
  4. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections. Emerg Infect Dis. 2019 10; 25(10):1868-1877.
    View in: PubMed
    Score: 0.027
  5. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol. 2017 04; 23:49-58.
    View in: PubMed
    Score: 0.022
  6. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat Commun. 2020 07 08; 11(1):3496.
    View in: PubMed
    Score: 0.007
  7. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020 07 06; 11(1):3436.
    View in: PubMed
    Score: 0.007
  8. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020 06 26; 5(48).
    View in: PubMed
    Score: 0.007
  9. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
    View in: PubMed
    Score: 0.007
  10. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020 05 04; 11(1):2251.
    View in: PubMed
    Score: 0.007
  11. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020 05 29; 368(6494):1012-1015.
    View in: PubMed
    Score: 0.007
  12. MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017. Emerg Infect Dis. 2019 12; 25(12):2333-2335.
    View in: PubMed
    Score: 0.007
  13. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. J Virol. 2019 08 15; 93(16).
    View in: PubMed
    Score: 0.007
  14. Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits. Viruses. 2019 04 24; 11(4).
    View in: PubMed
    Score: 0.006
  15. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microbes Infect. 2019; 8(1):516-530.
    View in: PubMed
    Score: 0.006
  16. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein. Emerg Microbes Infect. 2019; 8(1):1593-1603.
    View in: PubMed
    Score: 0.006
  17. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection. Sci Adv. 2018 08; 4(8):eaas9667.
    View in: PubMed
    Score: 0.006
  18. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science. 2016 Jan 01; 351(6268):77-81.
    View in: PubMed
    Score: 0.005
  19. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies. Nat Commun. 2021 03 17; 12(1):1715.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.